201 related articles for article (PubMed ID: 23963058)
1. A pilot study to compare fluoxetine, calcium, and placebo in the treatment of premenstrual syndrome.
Yonkers KA; Pearlstein TB; Gotman N
J Clin Psychopharmacol; 2013 Oct; 33(5):614-20. PubMed ID: 23963058
[TBL] [Abstract][Full Text] [Related]
2. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine in the treatment of premenstrual syndrome.
Ozeren S; Corakçi A; Yücesoy I; Mercan R; Erhan G
Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):167-70. PubMed ID: 9228499
[TBL] [Abstract][Full Text] [Related]
4. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
[TBL] [Abstract][Full Text] [Related]
6. A double-blind trial of four medications to treat severe premenstrual syndrome.
Diegoli MS; da Fonseca AM; Diegoli CA; Pinotti JA
Int J Gynaecol Obstet; 1998 Jul; 62(1):63-7. PubMed ID: 9722128
[TBL] [Abstract][Full Text] [Related]
7. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
Maranho MCMF; Guapo VG; de Rezende MG; Vieira CS; Brandão ML; Graeff FG; Lovick T; Del-Ben CM
Psychoneuroendocrinology; 2023 Nov; 157():106360. PubMed ID: 37572412
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
[TBL] [Abstract][Full Text] [Related]
10. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.
Steiner M; Korzekwa M; Lamont J; Wilkins A
Psychopharmacol Bull; 1997; 33(4):771-4. PubMed ID: 9493491
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.
Atmaca M; Kumru S; Tezcan E
Hum Psychopharmacol; 2003 Apr; 18(3):191-5. PubMed ID: 12672170
[TBL] [Abstract][Full Text] [Related]
13. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
14. Clinical crossroads: a 45-year-old woman with premenstrual dysphoric disorder.
Appleton PE
JAMA; 1999 Jun 23-30; 281(24):2283. PubMed ID: 10386546
[No Abstract] [Full Text] [Related]
15. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder.
Steiner M; Romano SJ; Babcock S; Dillon J; Shuler C; Berger C; Carter D; Reid R; Stewart D; Steinberg S; Judge R
BJOG; 2001 May; 108(5):462-8. PubMed ID: 11368130
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine in the treatment of premenstrual dysphoric disorder.
Carr RR; Ensom MH
Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
[TBL] [Abstract][Full Text] [Related]
17. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
[TBL] [Abstract][Full Text] [Related]
18. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
Roca CA; Schmidt PJ; Smith MJ; Danaceau MA; Murphy DL; Rubinow DR
Am J Psychiatry; 2002 Nov; 159(11):1876-81. PubMed ID: 12411222
[TBL] [Abstract][Full Text] [Related]
19. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
Pearlstein T; Yonkers KA
Expert Opin Pharmacother; 2002 Jul; 3(7):979-91. PubMed ID: 12083997
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
